Targeting CXCL16 and STAT1 augments immune checkpoint blockade therapy in triple-negative breast cancer by Bhavana Palakurthi, Shaneann R. Fross, Ian H. Guldner, Emilija Aleksandrovic, Xiyu Liu, Anna K. Martino, Qingfei Wang, Ryan A. Neff, Samantha M. Golomb, Cheryl Lewis, Yan Peng, Erin N. Howe, Siyuan Zhang

Get full text